Abstract—
SLC6A1 (Solute Carrier Family 6 Member 1) is a gene encoding GAT1, the gamma-aminobutyric acid (GABA) transporter protein. GAT1 is responsible for GABA reuptake from the synaptic cleft and intercellular space. Mutations in the SLC6A1 gene can lead to impaired GABA regulation and are associated with epilepsy and a number of mental disorders. In this review, we discuss the role of GAT1 protein in GABAergic regulation and the association of mutations in SLC6A1 gene with epilepsy, autism spectrum disorders, intellectual disability, and schizophrenia, as well as prospects for their treatment with genome editing systems.
Similar content being viewed by others
REFERENCES
www.uniprot.org/uniprot/P30531 (accessed: 11.05.2021).
Dalby, N.O., Neuropharmacology, 2000, vol. 39, no. 12, pp. 2399–2407.
Semyanov, A., Walker, M.C., and Kullmann, D.M., Nat. Neurosci., 2003, vol. 6, no. 5, pp. 484–490.
Keros, S. and Hablitz, J.J., J. Neurophysiol., 2005, vol. 94, no. 3, pp. 2073–2085.
Gong, N., et al., J. Neurosci., 2009, vol. 29, no. 50, pp. 15836–15845.
Andang, M., et al., Nature, 2008, vol. 451, no. 7177, pp. 460–464.
Ben-Ari, Y., Nat. Rev. Neurosci., 2002, vol. 3, no. 9, pp. 728–739.
Johannesen, K.M., et al., Epilepsia, 2018, vol. 59, no. 2, pp. 389–402.
Goodspeed, K., et al., Brain Commun., 2020, vol. 2, no. 2, p. fcaa170.
Carvill, G.L., et al., Am. J. Hum. Genet., 2015, vol. 96, no. 5, pp. 808–815.
Feng, Y.-C.A., et al., Am. J. Hum. Genet., 2019, vol. 105, no. 2, pp. 267–282.
Sanders, S.J., et al., Neuron, 2015, vol. 87, no. 6, pp. 1215–1233.
Satterstrom, F.K., et al., Cell, 2020, vol. 180, no. 3, pp. 568–584.
Bolton, P.F., et al., Br. J. Psychiatry, 2011, vol. 198, no. 4, pp. 289–294.
Nelson, S.B. and Valakh, V., Neuron, 2015, vol. 87, no. 4, pp. 684–698.
Rees, E., et al., Nat. Neurosci., 2020, vol. 23, no. 2, pp. 179–184.
Volk, D.W., et al., Am. J. Psychiatry, 2001, vol. 158, no. 2, pp. 256–265.
Hashimoto, T., et al., Am. J. Psychiatry, 2008, vol. 165, no. 4, pp. 479–489.
Bullock, W.M., et al., Am. J. Psychiatry, 2008, vol. 165, no. 12, pp. 1594–1603.
Hysi, P.G., et al., Nat. Genet., 2020, vol. 52, no. 4, pp. 401–407.
Lawrenson, K., et al., Gynecol. Oncol., 2019, vol. 153, no. 2, pp. 343–355.
Adkins, D.E., et al., Twin Res. Hum. Genet., 2015, vol. 18, no. 4, pp. 335–347.
Thoeringer, C.K., et al., J. Neural Transm., 2009, vol. 116, no. 6, pp. 649–657.
Lasky-Su, J., et al., Am. J. Med. Genet. B Neuropsychiatr. Genet., 2008, vol. 147B, no. 8, pp. 1345–1354.
Demontis, D., et al., Nat. Genet., 2019, vol. 51, no. 1, pp. 63–75.
Mattison, K.A., et al., Epilepsia, 2018, vol. 59, no. 9.
Yuan, F.-F., et al., Prog. Neuropsychopharmacol. Biol. Psychiatry, 2017, vol. 77, pp. 202–208.
Minelli, A., et al., J. Neurosci., 1996, vol. 16, no. 19, pp. 6255–6264.
Melone, M., Ciappelloni, S., and Conti, F., Brain Struct. Funct., 2015, vol. 220, no. 2, pp. 885–897.
Fattorini, G., Melone, M., and Sanchez-Gomez, M.V., Glia, 2017.
Fattorini, G., et al., Glia, 2020, vol. 68, no. 3, pp. 646–655.
Uhlen, M., et al., Science, 2015, vol. 347, no. 6220, p. 1260419.
Zhang, J., et al., Syst. Biol. Reprod. Med, 2009, vol. 55, nos. 5–6, pp. 175–180.
Kanner, B.I., Biochemistry, 1978, vol. 17, no. 7, pp. 1207–1211.
Radian, R. and Kanner, B.I., J. Biol. Chem., 1985, vol. 260, no. 21, pp. 11859–11865.
Guastella, J., et al., Science, 1990, vol. 249, no. 4974, pp. 1303–1306.
Zafar, S. and Jabeen, I., Front Chem., 2018, vol. 6, p. 397.
Risso, S., DeFelice, L.J., and Blakely, R.D., J. Physiol., 1996, vol. 490 (Pt 3), pp. 691–702.
Cammack, J.N. and Schwartz, E.A., Proc. Natl. Acad. Sci. USA, 1996, vol. 93, no. 2, pp. 723–727.
Stark, E., et al., Neuron, 2013, vol. 80, no. 5, pp. 1263–1276.
Pouille, F. and Scanziani, M., Science, 2001, vol. 293, no. 5532, pp. 1159–1163.
Hajos, N., et al., J. Neurosci., 2004, vol. 24, no. 41, pp. 9127–9137.
Akam, T. and Kullmann, D.M., Neuron, 2010, vol. 67, no. 2, pp. 308–320.
Brown, D.A., Neuropharmacology, 2018, vol. 136, pt. A, pp. 3–9.
Borden, L.A., Neurochem. Int., 1996, vol. 29, no. 4, pp. 335–356.
Iversen, L.L. and Kelly, J.S., Biochem. Pharmacol., 1975, vol. 24, no. 9, pp. 933–938.
Dingledine, R. and Korn, S.J., J. Physiol., 1985, vol. 366, pp. 387–409.
Isaacson, J.S., Solis, J.M., and Nicoll, R.A., Neuron, 1993, vol. 10, no. 2, pp. 165–175.
Overstreet, L.S. and Westbrook, G.L., J. Neurosci., 2003, vol. 23, no. 7, pp. 2618–2626.
Liu, G.-X., et al., J. Neurosci. Res, 2007, vol. 85, no. 3, pp. 649–655.
Liu, G.-X., et al., Neuropsychopharmacology, 2007, vol. 32, no. 7, pp. 1531–1539.
Xu, Y.F., et al., J. Neurosci. Res., 2008, vol. 86, no. 2, pp. 465–470.
Cai, Y.-Q., et al., J. Neurosci. Res., 2006, vol. 84, no. 2, pp. 255–267.
Chiu, C.-S., et al., J. Neurosci., 2002, vol. 22, no. 23, pp. 10251–10266.
Chiu, C.-S., et al., J. Neurosci., 2005, vol. 25, no. 12, pp. 3234–3245.
Quandt, G., Hofner, G., and Wanner, K.T., Bioorg. Med. Chem., 2013, vol. 21, no. 11, pp. 3363–3378.
Kristensen, A.S., et al., Pharmacol. Rev., 2011, vol. 63, no. 3, pp. 585–640.
Zhou, Y. and Danbolt, N.C., Front. Endocrinol, vol. 4, p. 165.
Scimemi, A., Front. Cell. Neurosci., 2014, vol. 8, p. 161.
Kavanaugh, M.P., et al., J. Biol. Chem., 1992, vol. 267, no. 31, pp. 22007–22009.
Ikegaki, N., et al., Brain Res. Mol. Brain Res., 1994, vol. 26, nos. 1–2, pp. 47–54.
Conti, F., Minelli, A., and Melone, M., Brain Res. Brain Res. Rev., 2004, vol. 45, no. 3, pp. 196–212.
Zhou, Y., et al., Am. J. Physiol. Renal Physiol., 2012, vol. 302, no. 3, pp. F316–F328.
www.genecards.org/cgi-bin/carddisp.pl?id=P30531 (accessed: 12.05.2021).
Braestrup, C., et al., J. Neurochem., 1990, vol. 54, no. 2, pp. 639–647.
https://swissmodel.expasy.org/repository/uniprot/P30-531?csm=094DB39C1D3B75D2 (accessed: 15.11.2020).
Dichter, M.A. and Ayala, G.F., Science, 1987, vol. 237, no. 4811, pp. 157–164.
Markram, H., et al., Nat. Rev. Neurosci., 2004, vol. 5, no. 10, pp. 793–807.
Markram, H., et al., Cell, 2015, vol. 163, no. 2, pp. 456–492.
Rudy, B., et al., Dev. Neurobiol., 2011, vol. 71, no. 1, pp. 45–61.
Petilla Interneuron Nomenclature Group, Nat. Rev. Neurosci., 2008, vol. 9, no. 7, pp. 557–568.
Kawaguchi, Y. and Kubota, Y., Cereb. Cortex, 1997, vol. 7, no. 6, pp. 476–486.
Buzsaki, G. and Draguhn, A., Science, 2004, vol. 304, no. 5679, pp. 1926–1929.
Gaetz, W., et al., Neuroimage, 2011, vol. 55, no. 2, pp. 616–621.
Lundqvist, M., et al., Neuron, 2016, vol. 90, no. 1, pp. 152–164.
Rojas, D.C. and Wilson, L.B., Biomark. Med., 2014, vol. 8, no. 3, pp. 353–368.
McNally, J.M. and McCarley, R.W., Curr. Opin. Psychiatry, 2016, vol. 29, no. 3, pp. 202–210.
Le Roux, N., et al., Eur. J. Neurosci., 2008, vol. 27, no. 12, pp. 3244–3256.
Boon, F.S., et al., Pflugers Arc., vol. 467, no. 7, pp. 1551–1564.
Gao, R. and Penzes, P., Curr. Mol. Med., 2015, vol. 15, no. 2, pp. 146–167.
Turrigiano, G.G. and Nelson, S.B., Nat. Rev. Neurosci., 2004, vol. 5, no. 2, pp. 97–107.
Kang, E., et al., Cell Rep., vol. 28, no. 6, pp. 1419–1428.
Arslan, A., Int. J. Mol. Sci., 2018, vol. 19, no. 1.
Akbarian, S., et al., Arch. Gen. Psychiatry, 1995, vol. 52, no. 4, pp. 258–266.
Volk, D.W., et al., Arch. Gen. Psychiatry, 2000, vol. 57, no. 3, pp. 237–245.
Guidotti, A., et al., Arch. Gen. Psychiatry, 2000, vol. 57, no. 11, pp. 1061–1069.
Hashimoto, T., et al., J. Neurosci., 2003, vol. 23, no. 15, pp. 6315–6326.
Williams, H.J., et al., Am. J. Psychiatry, 2005, vol. 162, no. 9, pp. 1736–1738.
Arslan, A., Prog. Neuropsychopharmacol. Biol. Psychiatry, 2018, vol. 80, pp. 155–165.
Bormann, J., Trends Pharmacol. Sci., 2000, vol. 21, no. 1, pp. 16–19.
Zhang, D., et al., Trends Pharmacol. Sci., 2001, vol. 22, no. 3, pp. 121–132.
Chebib, M., Clin. Exp. Pharmacol. Physiol., 2004, vol. 31, no. 11, pp. 800–804.
Mehta, A.K. and Ticku, M.K., Brain Res. Brain Res. Rev., 1999, vol. 29, nos. 2–3, pp. 196–217.
Costa, E., Annu. Rev. Pharmacol. Toxicol., 1998, vol. 38, pp. 321–350.
Bianchi, M.T., Haas, K.F., and Macdonald, R.L., J. Neurosci., 2001, vol. 21, no. 4, pp. 1127–1136.
Lee, Y.H., Kim, J.-H., and Song, G.G., Gene, 2013, vol. 525, no. 1, pp. 107–115.
Lencz, T., et al., Nat. Commun., 2013, vol. 4, p. 2739.
Ripke, S., et al., Nat. Genet., 2013, vol. 45, no. 10, pp. 1150–1159.
Bettler, B. and Tiao, J.Y.-H., Pharmacol. Ther., 2006, vol. 110, no. 3, pp. 533–543.
Jackson, M.F., Esplin, B., and Capek, R., Epilepsy Res, 1999, vol. 37, no. 1, pp. 25–36.
Brooks-Kayal, A.R., et al., Nat. Med., 1998, vol. 4, no. 10, pp. 1166–1172.
Bethmann, K., et al., Neurobiol. D., vol. 31, no. 2, pp. 169–187.
Jones, K.A., et al., Nature, 1998, vol. 396, no. 6712, pp. 674–679.
Couve, A., Moss, S.J., and Pangalos, M.N., Mol. Cell. Neurosci., 2000, vol. 16, no. 4, pp. 296–312.
Mott, D.D. and Lewis, D.V., Int. Rev. Neurobiol., 1994, vol. 36, pp. 97–223.
Scanziani, M., Neuron, 2000, vol. 25, no. 3, pp. 673–681.
Misgeld, U., Bijak, M., and Jarolimek, W., Prog. Neurobiol., 1995, vol. 46, no. 4, pp. 423–462.
Andrade, R., Malenka, R.C., and Nicoll, R.A., Science, 1986, vol. 234, no. 4781, pp. 1261–1265.
Freund, T.F. and Buzsaki, G., Hippocampus, 1996, vol. 6, no. 4, pp. 347–470.
Miles, R., et al., Neuron, 1996, vol. 16, no. 4, pp. 815–823.
Gaspary, H.L., Wang, W., and Richerson, G.B., J. Neurophysiol., 1998, vol. 80, no. 1, pp. 270–281.
Liu, Q.Y., et al., J. Neurophysiol., 2000, vol. 84, no. 3, pp. 1392–1403.
Overstreet, L.S. and Westbrook, G.L., J. Neurophysiol., 2001, vol. 86, no. 2, pp. 596–603.
Brickley, S.G., Cull-Candy, S.G., and Farrant, M., J. Physiol., 1996, vol. 497.
Rossi, D.J. and Hamann, M., Neuron, 1998, vol. 20, no. 4, pp. 783–795.
Rivera, C., et al., Nature, 1999, vol. 397, no. 6716, pp. 251–255.
Ganguly, K., et al., Cell, 2001, vol. 105, no. 4, pp. 521–532.
Ben-Ari, Y., et al., Prog. Brain Res, 1994, vol. 102, pp. 261–273.
Jensen, K., et al., J. Neurophysiol., 2003, vol. 90, no. 4, pp. 2690–2701.
Bragina, L., et al., J. Neurochem., 2008, vol. 105, no. 5, pp. 1781–1793.
Conti, F., et al., Front. Cell. Neurosci, 2011, vol. 5, p. 2.
Owens, D.F. and Kriegstein, A.R., Nat. Rev. Neurosci, 2002, vol. 3, no. 9, pp. 715–727.
Cellot, G. and Cherubini, E., Front. Neural Circuits, 2013, vol. 7, p. 136.
Manent, J.-B., et al., J. Neurosci., 2005, vol. 25, no. 19, pp. 4755–4765.
Behar, T.N., et al., Cereb. Cortex, 2001, vol. 11, no. 8, pp. 744–753.
Behar, T.N., et al., Cereb. Cortex, 2000, vol. 10, no. 9, pp. 899–909.
Aronne, M.P., et al., Exp. Neurol., 2011, vol. 229, no. 2, pp. 364–371.
Cuzon, V.C., et al., J. Neurosci., 2008, vol. 28, no. 8, pp. 1854–1864.
Haas, M., et al., Eur. J. Neurosci., 2013, vol. 37, no. 10, pp. 1584–1593.
Manent, J.-B., et al., Epilepsia, 2007, vol. 48, no. 4, pp. 684–693.
Thompson, B.L., Levitt, P., and Stanwood, G.D., Nat. Rev. Neurosci., 2009, vol. 10, no. 4, pp. 303–312.
Wu, X., et al., J. Neurosci., 2012, vol. 32, no. 1, pp. 331–343.
Trinchero, M.F., Giacomini, D., and Schinder, A.F., Curr. Opin. Neurobiol., 2021, vol. 69, pp. 124–130.
Huang, E.J. and Reichardt, L.F., Annu. Rev. Neurosci., 2001, vol. 24, pp. 677–736.
Marin, O. and Rubenstein, J.L., Nat. Rev. Neurosci., 2001, vol. 2, no. 11, pp. 780–790.
Park, H. and Poo, M.-M., Nat. Rev. Neurosci., 2013, vol. 14, no. 1, pp. 7–23.
Knusel, B., et al., J. Neurosci., 1994, vol. 14, no. 3, pp. 1542–1554.
Polleux, F., et al., Development, 2002, vol. 129, no. 13, pp. 3147–3160.
Woo, N.H. and Lu, B., Neuroscientist, 2006, vol. 12, no. 1, pp. 43–56.
Gorski, J.A., et al., J. Neurosci., 2003, vol. 23, no. 17, pp. 6856–6865.
Vicario-Abejon, C., et al., Nat. Rev. Neurosci., 2002, vol. 3, no. 12, pp. 965–974.
Paus, T., Keshavan, M., and Giedd, J.N., Nat. Rev. Neurosci, 2008, vol. 9, no. 12, pp. 947–957.
Farhan, H., Freissmuth, M., and Sitte, H.H., Handb. Exp. Pharmacol, 2006, no. 175, pp. 233–249.
Berninger, B., et al., Development, 1995, vol. 121, no. 8, pp. 2327–2335.
Marty, S., et al., J. Neurosci., 1996, vol. 16, no. 2, pp. 675–687.
Arion, D. and Lewis, D.A., Arch. Gen. Psychiatry, 2011, vol. 68, no. 1, pp. 21–31.
Hyde, T.M., et al., J. Neurosci., 2011, vol. 31, no. 30, pp. 11088–11095.
Ben-Ari, Y., et al., J. Physiol., 1989, vol. 416, pp. 303–325.
Blume, W.T., et al., Epilepsia, 2001, vol. 42, no. 9, pp. 1212–1218.
Chen, L., et al., Acta Neuropsychiatr., 2015, vol. 27, no. 6, pp. 368–374.
Cope, D.W., et al., Nat. Med, 2009, vol. 15, no. 12, pp. 1392–1398.
Han, H.A., Cortez, M.A., and Snead, O.C., Gabab receptor and absence epilepsy, Jasper’s Basic Mechanisms of the Epilepsies, Noebels, J.L. , Eds., Bethesda (MD): National Center for Biotechnology Information (US), 2012.
Khosravani, H. and Zamponi, G.W., Physiol. Rev., 2006, vol. 86, no. 3, pp. 941–966.
Snead, O.C., 3rd, Eur. J. Pharmacol., 1992, vol. 213, no. 3, pp. 343–349.
Zhang, L., et al., Neuropsychopharmacology, 2016, vol. 41, no. 6, pp. 1467–1476.
Macdonald, R.L., Kang, J.-Q., and Gallagher, M.J., J. Physiol., 2010, vol. 588.
Yu, Z., et al., PLoS One, 2013, vol. 8, no. 7.
Cai, K., et al., Exp. Neurol. Elsevier, 2019, vol. 320.
Parikshak, N.N., et al., Cell, 2013, vol. 155, no. 5, pp. 1008–1021.
Iakoucheva, L.M., Muotri, A.R., and Sebat, J., Cell, 2019, vol. 178, no. 6, pp. 1287–1298.
Grove, J., et al., Nat. Genet. Nature America, Inc., 2019, vol. 51, no. 3, pp. 431–444.
Di, J., et al., Int. J. Dev. Neurosci, 2020, vol. 80, no. 2, pp. 73–85.
Delahanty, R.J., et al., Mol. Psychiatry, 2011, vol. 16, no. 1, pp. 86–96.
Han, S., et al., Nature, 2012, vol. 489, no. 7416, pp. 385–390.
Kang, J.-Q. and Barnes, G., J. Autism Dev. Disord., 2013, vol. 43, no. 1, pp. 68–79.
Wang, J., et al., Mol. Brain, 2020, vol. 13, no. 1, p. 76.
Devries, S., et al., Cold Spring Harb. Mol. Case Stud., 2020.
Posar, A. and Visconti, P., J. Pediatr. Neurosci., 2019, vol. 14, no. 2, pp. 100–102.
Ferguson, B.R. and Gao, W.-J., Front. Neural Circuits, 2018, vol. 12, p. 37.
Singh, T., et al., Nat. Genet., 2017, vol. 49, no. 8, pp. 1167–1173.
Fromer, M., et al., Nature, 2014, vol. 506, no. 7487, pp. 179–184.
Lee, J. and Park, S., J. Abnorm. Psychol., 2005, vol. 114, no. 4, pp. 599–611.
Insel, T.R., Nature, 2010, vol. 468, no. 7321, pp. 187–193.
Tse, M.T., Piantadosi, P.T., and Floresco, S.B., Biol. Psychiatry, 2015, vol. 77, no. 11, pp. 929–939.
Hashimoto, T., et al., Mol. Psychiatry, 2008, vol. 13, no. 2, pp. 147–161.
Wray, N.R. and Visscher, P.M., Schizophr. Bull., 2010, vol. 36, no. 1, pp. 14–23.
Gejman, P.V., Sanders, A.R., and Duan, J., Psychiatr. Clin. North Am., 2010, vol. 33, no. 1, pp. 35–66.
Martin, A.R., et al., Biol. Psychiatry, 2019, vol. 86, no. 2, pp. 97–109.
Ma, C., et al., Transl. Psychiatry, 2018, vol. 8, no. 1.
Pardinas, A.F., et al., Nat. Genet., 2018, vol. 50, no. 3, pp. 381–389.
Tansey, K.E., et al., Mol. Psychiatry, 2016, vol. 21, no. 8, pp. 1085–1089.
Pocklington, A.J., et al., Neuron, 2015, vol. 86, no. 5, pp. 1203–1214.
Ripke, S., et al., Nature, 2014, vol. 511, no. 7510, pp. 421–427.
Wray, N.R., et al., J. Child Psychol. Psychiatry, 2014, vol. 55, no. 10, pp. 1068–1087.
Bush, W.S. and Moore, J.H., PLoS Comput. Biol, 2012, vol. 8, no. 12.
Sullivan, P.F., Daly, M.J., and O’Donovan, M., Nat. Rev. Genet., 2012, vol. 13, no. 8, pp. 537–551.
St, ClairD., Schizophr. Bull., 2009, vol. 35, no. 1, pp. 9–12.
Cook, E.H.Jr. and Scherer, S.W., Nature, 2008, vol. 455, no. 7215, pp. 919–923.
Gulsuner, S., et al., Cell, 2013, vol. 154, no. 3, pp. 518–529.
Singh, T., et al., Eur. Neuropsychopharmacol., 2019, vol. 29, pp. 813–S814.
Lewis, D.A., Hashimoto, T., and Volk, D.W., Nat. Rev. Neurosci., 2005, vol. 6, no. 4, pp. 312–324.
Opris, I. and Bruce, C.J., Brain Res. Brain Res. Rev., 2005, vol. 48, no. 3, pp. 509–526.
Sem’yanov, A.V., Neirofiziologiya. Researchgate.net, 2002.
Somogyi, P. and Klausberger, T., J. Physiol., 2005, vol. 562.
Lewis, D.A., et al., Trends Neurosci., 2012, vol. 35, no. 1, pp. 57–67.
Lisman, J., Curr. Opin. Neurobiol, 2012, vol. 22, no. 3, pp. 537–544.
Basar-Eroglu, C., et al., Int. J. Psychophysiol., 2007, vol. 64, no. 1, pp. 39–45.
Wang, D., Tai, P.W.L., and Gao, G., Nat. Rev. Drug Discov., 2019, vol. 18, no. 5, pp. 358–378.
Foust, K.D., et al., Nat. Biotechnol., 2010, vol. 28, no. 3, pp. 271–274.
Fu, H., et al., Mol. Ther., 2011, vol. 19, no. 6, pp. 1025–1033.
Kaplitt, M.G., et al., Lancet, 2007, vol. 369, no. 9579, pp. 2097–2105.
Bolt, M.W., et al., J. Toxicol. Sci., 2021, vol. 46, no. 2, pp. 57–68.
Shivram, H., et al., Nat. Chem. Biol., 2021, vol. 17, no. 1, pp. 10–19.
Weiss, W.F., Ther. Innov. Regul. Sci., 2021.
Nishiyama, J., Mikuni, T., and Yasuda, R., Neuron, 2017, vol. 96, no. 4, pp. 755–768.
Matsuda, T. and Oinuma, I., Sci. Rep., vol. 9, no. 1, p. 11309.
Xue, C. and Greene, E.C., Trends Genet., 2021.
Fu, Y.-W., et al., Nucleic Acid Res., 2021, vol. 49, no. 2, pp. 969–985.
Anzalone, A.V., et al., Nature, 2019, vol. 576, no. 7785, pp. 149–157.
Ridley, R.B., Walsh, E.M., and Ildefonso, C.J., Methods Mol. Biol, 2021, vol. 2225, pp. 77–92.
Sledzinski, P., et al., Biotechnol. Adv., 2021, vol. 49, p. 107737.
Visscher, P.M., et al., Am. J. Hum. Genet., 2012, vol. 90, no. 1, pp. 7–24.
Malhotra, D. and Sebat, J., Cell, 2012, vol. 148, no. 6, pp. 1223–1241.
Yuan, H., et al., BMC Med. Genet, 2020, vol. 21, no. 1, p. 93.
Golov, A.K., et al., Cells, 2020, vol. 9, no. 1, p. 246.
Funding
E.S. Bukina, N.V. Kondratyev, and V.E. Golimbet were financially supported by the grant of the Russian Science Foundation no. 21-15-00124.
A.S. Artyuhov was supported by the SkolTech grant on Systems Biology.
E.S. Bukina and E.B. Dashinimaev were supported by the grant of the Ministry of Science and Higher Education, Center for High Precision Genomic Editing and Genetic Technologies for Biomedicine no. 075-15-2019-1789.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests. The authors declare that they have no conflict of interests.
Rights and permissions
About this article
Cite this article
Bukina, E.S., Kondratyev, N.V., Kozin, S.V. et al. SLC6A1 and Neuropsychiatric Diseases: The Role of Mutations and Prospects for Treatment with Genome Editing Systems. Neurochem. J. 15, 376–389 (2021). https://doi.org/10.1134/S1819712421040048
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712421040048